Table 1. Patient Demographics.
| N (% or range) | |
|---|---|
| All | 258 |
| Median age in years | 48 (20-71) |
| Sex | |
| Male | 145 (56) |
| Female | 113 (44) |
| Disease | |
| ALL, AML, MDS | 117 (45) |
| CML, IMF, MPD | 34 (13) |
| CLL | 21 (8) |
| HL, NHL | 58 (23) |
| MM | 15 (6) |
| AA, PNH | 8 (3) |
| Othera | 5 (2) |
| Conditioning Regimen | |
| Myeloablative | 138 (53) |
| Non-Myeloablative | 118 (46) |
| Unknown | 2 (1) |
| Total Body Irradiation | |
| Yes | 90 (35) |
| No | 166 (64) |
| Unknown | 2 (1) |
| Stem Cell Source | |
| BM | 39 (15) |
| PBSC | 216 (84) |
| Cord | 3 (1) |
| Donor Relationship | |
| Related | 161 (62) |
| Unrelated | 96 (37) |
| Unknown | 1 (<1) |
| HLA Match | |
| Yes | 221 (86) |
| No | 32 (12) |
| Unknown | 5 (2) |
a
Other includes Ewing's sarcoma (n=2), essential thrombocythemia (n=1), sickle cell anemia (n=1), and Wiskott-Aldrich syndrome (n=1).
Abbreviations: ALL–acute lymphocytic leukemia, AML–acute myeloid leukemia, MDS–myelodysplastic syndrome, CML–chronic myeloid leukemia, IMF–idiopathic myelofibrosis, MPD–myeloproliferative disorder, CLL–chronic lymphocytic leukemia, HL–Hodgkin's lymphoma, NHL–non-Hodgkin's lymphoma, MM–multiple myeloma, AA–aplastic anemia, PNH–paroxysmal nocturnal hemoglobinuria, BM–bone marrow, PBSC–peripheral blood stem cells, HLA–human leukocyte antigen